GlobalData recently published their top 20 global pharma companies categorized by market capitalization in the first quarter of 2019.
1、GlobalData Report: Top 20 Pharma Companies Lost $2.6 Trillion Market Cap in Q1 2、COVID-19 drained 8% of market value from Big Pharma in Q1, but Gilead andRegeneronsoared: report 3、GlobalData sees mild reversal in fortune for top 20 global innovative pharma companies by market capitalizat...
1.https://www.biospace.com/article/eli-lilly-edges-out-j-and-j-to-top-20-biopharma-market-cap-list-for-2023-/ 2.https://www.globaldata.com/media/business-fundamentals/top-20-global-biopharmaceutical-companies-report-1-6-market-capitalization-growth-to-3-67-trillion-in-2023-reveals-globaldata...
Comprehensively, the top 10 Pharma companies in South Korea had a total market cap of $35,985 million (as of Mar 31, 2023), with Celltrion Inc having the highest ($16,907 million), followed by SK Bioscience Ltd ($4,270 million), and SK Biopharmaceuticals Co Ltd ($3,823 million), ...
TechTarget.com/pharmalifesciences https://www.techtarget.com/pharmalifesciences/feature/Exploring-the-top-20-biopharma-companies-Q1-2024-market-cap-growthsExploring the top 20 biopharma companies Q1 2024 market cap growthsBy Alivia Kaylor, MSc...
Swiss companies Roche and Novartis held the second and third place among European pharma and biotech companies, accumulating a market capitalization of approximately 255 billion U.S.
The performance highlights of the Top 25 publicly traded global Pharma companies for the year 2017 have been confirmed in the latest research from GlobalData, a leading data and analytics company. The completed analysis reveals a number of interesting insights. The pharma sector’s 2017 v 2016 yea...
Pharmaceutical market: worldwide revenue 2001-2023 Top global pharmaceutical companies based on pharma revenue 2022 Top 10 biotech and pharmaceutical companies based on market cap 2024 Projected top pharmaceutical companies based on sales 2023 Top drugs based on projected 2024 global sales ...
近日,外媒 BioSpace 团队根据市值收集了前 20 家生物制药公司 CEO 的最新底薪信息,范围在 115 万美元-670.7 万美元。 下表除了展示基本薪资外,还与上一年做了对比。一些 CEO 只有几个百分点的轻微增长。然而,诺华和吉利德因对抗新冠药物 Remdesivir 业绩大涨,诺华 C...
iShares Nasdaq Top 30 Stocks ETF seeks to track the investment results of an index composed of the 30 largest companies by market capitalization within the Nasdaq 100 Index.